Urology Doctors in Lewes, DE Accepting Medicare

3 Urology doctors found. Showing 1 - 3

Dr. Ramachandra Umesh Hosmane, M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1408 Savannah Rd, Lewes, DE 19958 Phone: 302-645-2274    Fax: 302-645-2275

Delbert J Kwan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 34431 King Street Row, Lewes, DE 19958 Phone: 302-645-2666    Fax: 302-645-6448

Richard Campbell Paul, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 34431 King Street Row, Lewes, DE 19958 Phone: 302-645-2666    Fax: 302-645-6448

News Archive

Clinical Solutions introduces 'Seven competencies for e-care'

Clinical Solutions, the leading provider of health-based customer relationship management (CRM) and clinical content solutions, is today launching the 'Seven competencies of e-care' as the focal point for its new market strategy and website http://www.clinicalsolutions.com.

Study explores secondhand smoke exposure rates among nonsmoking adult cancer survivors

From 1999/2000 to 2011/2012, exposure to secondhand smoke among nonsmoking adult cancer survivors declined from 39.6 percent to 15.7 percent, but rates of exposure were higher among those with a history of a smoking-related cancer and those living below the federal poverty level compared with those with other types of cancer and those with the highest incomes, respectively.

BMS survey: Only half of GP practice buildings are fit for purpose

Only half of GP practice buildings in England are fit for purpose, with surgeries too small to meet the demands of growing populations, a major survey on practice premises from the British Medical Association has found.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Abbvie presents venetoclax Phase 1 results in patients with multiple myeloma at ASCO 2015

AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.

Read more Medical News

› Verified 5 days ago